AstraZeneca’s (AZN) Buy Rating Reiterated at Shore Capital
Shore Capital restated their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a report released on Friday morning, Marketbeat.com reports. A number of other equities research analysts have also commented on AZN. JPMorgan Chase & Co. restated an “overweight” rating on shares of AstraZeneca in a research report on Wednesday, February 19th. […]
